Rare tumors in children: Progress through collaboration

Journal of Clinical Oncology

Volumn 33, Issue 27, 2015, Pages 3047-3054

  Pappo, Alberto S ^a   Furman, Wayne L ^a   Schultz, Kris A ^b   Ferrari, Andrea ^c   Helman, Lee ^d   Krailo, Mark D ^e  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b CHILDREN S HOSPITALS AND CLINICS OF MINNESOTA   (United States)

^c NATIONAL CANCER INSTITUTE   (Italy)

^d NATIONAL CANCER INSTITUTE   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CENTER; CANCER REGISTRY; CANCER RESEARCH; CHILD; CHILDHOOD CANCER; COOPERATION; GASTROINTESTINAL STROMAL TUMOR; HEPATOBLASTOMA; HUMAN; NATIONAL HEALTH ORGANIZATION; PRIORITY JOURNAL; RARE DISEASE; REVIEW; ADOLESCENT; INTERDISCIPLINARY COMMUNICATION; INTERNATIONAL COOPERATION; MASS COMMUNICATION; MORTALITY; NEOPLASMS; ONCOLOGY; ONSET AGE; PEDIATRICS; RARE DISEASES; SURVIVOR; TIME; TREATMENT OUTCOME; TRENDS; YOUNG ADULT;

ADOLESCENT; AGE OF ONSET; CHILD; COOPERATIVE BEHAVIOR; DIFFUSION OF INNOVATION; HUMANS; INTERDISCIPLINARY COMMUNICATION; INTERNATIONAL COOPERATION; MEDICAL ONCOLOGY; NEOPLASMS; PEDIATRICS; RARE DISEASES; SURVIVORS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84942236059     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2014.59.3632     Document Type: Review

References (59)

1. Siegel R, Ma J, Zou Z, et al: Cancer statistics, 2014. CA Cancer J Clin 64:9-29, 2014
2. Bisogno G, Ferrari A, Bien E, et al: Rare cancers in children: The EXPeRT initiative-A report from the European Cooperative Study Group on Pediatric Rare Tumors. Klin Padiatr 224:416-420, 2012
3. Pappo AS, Krailo M, Chen Z, et al: Infrequent tumor initiative of the Children's Oncology Group: Initial lessons learned and their impact on future plans. J Clin Oncol 28:5011-5016, 2010
4. Ries LAG, Smith MA, Gurney JG, et al: Cancer incidence and survival among children and adolescents: United States SEER Program 1975-1995. Bethesda, MD, National Cancer Institute, NIH publication No. 99-4649 1999
5. Shaw PH, Hayes-Lattin B, Johnson R, et al: Improving enrollment in clinical trials for adolescents with cancer. Pediatrics 133:S109-S113, 2014 (suppl 3)
6. Ferrari A, Bisogno G, De Salvo GL, et al: The challenge of very rare tumours in childhood: The Italian TREP project. Eur J Cancer 43:654-659, 2007
7. Virgone C, Cecchetto G, Alaggio R, et al: Appendiceal neuroendocrine tumours in childhood: Italian TREP project. J Pediatr Gastroenterol Nutr 58:333-338, 2014
8. Casanova M, Bisogno G, Gandola L, et al: A prospective protocol for nasopharyngeal carcinoma in children and adolescents: The Italian Rare Tumors in Pediatric Age (TREP) project. Cancer 118:2718-2725, 2012
9. Carretto E, Inserra A, Ferrari A, et al: Epithelial thymic tumours in paediatric age: A report from the TREP project. Orphanet J Rare Dis 6:28, 2011
10. Dall'igna P, Cecchetto G, Bisogno G, et al: Pancreatic tumors in children and adolescents: The Italian TREP project experience. Pediatr Blood Cancer 54:675-680, 2010
11. Gatta G, Botta L, Rossi S, et al: Childhood cancer survival in Europe 1999-2007: Results of EUROCARE-5-A population-based study. Lancet Oncol 15:35-47, 2014
12. Musselman JR, Spector LG, Krailo MD, et al: The Children's Oncology Group Childhood Cancer Res Network (CCRN): Case catchment in the United States. Cancer 120:3007-3015, 2014
13. Douglass EC, Green AA, Wrenn E, et al: Effective cisplatin (DDP) based chemotherapy in the treatment of hepatoblastoma. Med Pediatr Oncol 13:187-190, 1985
14. Douglass EC, Reynolds M, Finegold M, et al: Cisplatin, vincristine, and fluorouracil therapy for hepatoblastoma: A Pediatric Oncology Group study. J Clin Oncol 11:96-99, 1993
15. Ortega JA, Krailo MD, Haas JE, et al: Effective treatment of unresectable or metastatic hepatoblastoma with cisplatin and continuous infusion doxorubicin chemotherapy: A report from the Children's Cancer Study Group. J Clin Oncol 9:2167-2176, 1991
16. Ortega JA, Douglass EC, Feusner JH, et al: Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: A report from the Children's Cancer Group and the Pediatric Oncology Group. J Clin Oncol 18:2665-2675, 2000
17. Fuchs J, Rydzynski J, von Schweinitz D, et al: Pretreatment prognostic factors and treatment results in children with hepatoblastoma: A report from the German Cooperative Pediatric Liver Tumor Study HB 94. Cancer 95:172-182, 2002
18. Perilongo G, Maibach R, Shafford E, et al: Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma. N Engl J Med 361: 1662-1670, 2009
19. Hishiki T, Matsunaga T, Sasaki F, et al: Outcome of hepatoblastomas treated using the Japanese Study Group for Pediatric Liver Tumor (JPLT) protocol-2: Report from the JPLT. Pediatr Surg Int 27:1-8, 2011
20. Malogolowkin MH, Katzenstein HM, Meyers RL, et al: Complete surgical resection is curative for children with hepatoblastoma with pure fetal histology: A report from the Children's Oncology Group. J Clin Oncol 29:3301-3306, 2011
21. Pritchard J, Brown J, Shafford E, et al: Cisplatin, doxorubicin, and delayed surgery for childhood hepatoblastoma: A successful approach-Results of the first prospective study of the International Society of Pediatric Oncology. J Clin Oncol 18:3819-3828, 2000
22. Zsiros J, Brugieres L, Brock P, et al: Dosedense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): A prospective, single-arm, feasibility study. Lancet Oncol 14:834-842, 2013
23. Tomlinson GE, Douglass EC, Pollock BH, et al: Cytogenetic evaluation of a large series of hepatoblastomas: Numerical abnormalities with recurring aberrations involving 1q12-q21. Genes Chromosomes Cancer 44:177-184, 2005
24. Roebuck DJ, Aronson D, Clapuyt P, et al: PRETEXT: A revised staging system for primary malignant liver tumours of childhood developed by the SIOPEL group. Pediatr Radiol 37:123-132, 2007; quiz 249-250
25. López-Terrada D, Alaggio R, de Dávila MT, et al: Towards an international pediatric liver tumor consensus classification: Proceedings of the Los Angeles COG liver tumors symposium. Mod Pathol 27:472-491, 2014
26. Otte JB, Meyers R: PLUTO first report. Pediatr Transplant 14:830-835, 2010
27. Messinger YH, Stewart DR, Priest JR, et al: Pleuropulmonary blastoma: A report on 350 central pathology-confirmed pleuropulmonary blastoma cases by the International Pleuropulmonary Blastoma Registry. Cancer 121:276-285, 2015
28. Hill DA, Jarzembowski JA, Priest JR, et al: Type I pleuropulmonary blastoma: Pathology and biology study of 51 cases from the international pleuropulmonary blastoma registry. Am J Surg Pathol 32:282-295, 2008
29. Priest JR, Williams GM, Hill DA, et al: Pulmonary cysts in early childhood and the risk of malignancy. Pediatr Pulmonol 44:14-30, 2009
30. Hill DA, Ivanovich J, Priest JR, et al: DICER1 mutations in familial pleuropulmonary blastoma. Science 325:965, 2009
31. International Pleuropulmonary Blastoma Registry. http://www.PPBregistry.org
32. Doros L, Schultz KA, Stewart DR, et al: DICER1-related disorders, in Pagon RA, Adam MP, Ardinger HH, et al (eds): GeneReviews. Seattle, WA, University of Washington, 2014
33. Slade I, Bacchelli C, Davies H, et al: DICER1 syndrome: Clarifying the diagnosis, clinical features and management implications of a pleiotropic tumour predisposition syndrome. J Med Genet 48: 273-278, 2011
34. Doros L, Yang J, Dehner L, et al: DICER1 mutations in embryonal rhabdomyosarcomas from children with and without familial PPB-tumor predisposition syndrome. Pediatr Blood Cancer 59:558-560, 2012
35. Doros LA, Rossi CT, Yang J, et al: DICER1 mutations in childhood cystic nephroma and its relationship to DICER1-renal sarcoma. Mod Pathol 27:1267-1280, 2014
36. Pugh TJ, Yu W, Yang J, et al: Exome sequencing of pleuropulmonary blastoma reveals frequent biallelic loss of TP53 and two hits in DICER1 resulting in retention of 5p-derived miRNA hairpin loop sequences. Oncogene 33:5295-5302, 2014
37. Doros LA SK, Harris A, Williams GM, et al: IVADo treatment of type II and type III pleuropulmonary balstoma (PPB): A report form the International PPB Registry. J Clin Oncol 32:659s, 2014 (suppl 15s; abstr 10060)
38. Schultz KA, Pacheco MC, Yang J, et al: Ovarian sex cord-stromal tumors, pleuropulmonary blastoma and DICER1 mutations: A report from the International Pleuropulmonary Blastoma Registry. Gynecol Oncol 122:246-250, 2011
39. Schultz KAP, Harris A, Doros LA, et al: Clinical and genetic aspects of ovarian stromal tumors: A report from the International Ovarian and Testicular Stromal Tumor Registry. J Clin Oncol 32:355s, 2014 (suppl 15s; abstr 5520)
40. Schultz KA, Harris A, Williams GM, et al: Judicious DICER1 testing and surveillance imaging facilitates early diagnosis and cure of pleuropulmonary blastoma. Pediatr Blood Cancer 61:1695-1697, 2014
41. Miettinen M, Lasota J: Gastrointestinal stromal tumors. Gastroenterol Clin North Am 42:399-415, 2013
42. Corless CL, Barnett CM, Heinrich MC: Gastrointestinal stromal tumours: Origin and molecular oncology. Nature reviews. Cancer 11:865-878, 2011
43. International Ovarian and Testicular Stromal Tumor Registry. http://www.OTSTregistry.org
44. von Mehren M, Randall RL, Benjamin RS, et al: Gastrointestinal stromal tumors, version 2.2014. J Natl Compr Canc Netw 12:853-862, 2014
45. Pantaleo MA, Nannini M, Corless CL, et al: Quadruple wild-type (WT) GIST: Defining the subset of GIST that lacks abnormalities of KIT, PDGFRA, SDH, or RAS signaling pathways. Cancer Med 4:101-103, 2015
46. Miettinen M, Lasota J: Succinate dehydrogenase deficient gastrointestinal stromal tumors (GISTs): A review. Int J Biochem Cell Biol 53:514-519, 2014
47. Pasini B, McWhinney SR, Bei T, et al: Clinical and molecular genetics of patients with the Carney-Stratakis syndrome and germline mutations of the genes coding for the succinate dehydrogenase subunits SDHB, SDHC, and SDHD. Eur J Hum Genet 16:79-88, 2008
48. Agaram NP, Laquaglia MP, Ustun B, et al: Molecular characterization of pediatric gastrointestinal stromal tumors. Clin Cancer Res 14:3204-3215, 2008
49. Pappo AS, Janeway KA: Pediatric gastrointestinal stromal tumors. Hematol Oncol Clin North Am 23:15-34, vii, 2009
50. Miettinen M, Wang ZF, Sarlomo-Rikala M, et al: Succinate dehydrogenase-deficient GISTs: A clinicopathologic, immunohistochemical, and molecular genetic study of 66 gastric GISTs with predilection to young age. Am J Surg Pathol 35:1712-1721, 2011
51. Janeway KA, Kim SY, Lodish M, et al: Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations. Proc Natl Acad Sci U S A 108:314-318, 2011
52. Killian JK, Kim SY, Miettinen M, et al: Succinate dehydrogenase mutation underlies global epigenomic divergence in gastrointestinal stromal tumor. Cancer Discov 3:648-657, 2013
53. Wong JR, Harris JK, Rodriguez-Galindo C, et al: Incidence of childhood and adolescent melanoma in the United States: 1973-2009. Pediatrics 131:846-854, 2013
54. Flaherty KT, Hodi FS, Fisher DE: From genes to drugs: Targeted strategies for melanoma. Nat Rev Cancer 12:349-361, 2012
55. National Cancer Institute: NIH Pediatric and Wild-Type GIST Clinic. http://www.pediatricgist.cancer.gov/Source/NIHGISTClinic/NIHGistClinic.aspx
56. Evans AE, Land VJ, Newton WA, et al: Combination chemotherapy (vincristine, adriamycin, cyclophosphamide, and 5-fluorouracil) in the treatment of children with malignant hepatoma. Cancer 50: 821-826, 1982
57. von Schweinitz D, Byrd DJ, Hecker H, et al: Efficiency and toxicity of ifosfamide, cisplatin and doxorubicin in the treatment of childhood hepatoblastoma: Study Committee of the Cooperative Paediatric Liver Tumour Study HB89 of the German Society for Paediatric Oncology and Haematology. Eur J Cancer 33:1243-1249, 1997
58. Sasaki F, Matsunaga T, Iwafuchi M, et al: Outcome of hepatoblastoma treated with the JPLT-1 (Japanese Study Group for Pediatric Liver Tumor) protocol-1: A report from the Japanese Study Group for Pediatric Liver Tumor. J Pediatr Surg 37:851-856, 2002
59. Perilongo G, Shafford E, Maibach R, et al: Risk-adapted treatment for childhood hepatoblastoma. final report of the second study of the International Society of Paediatric Oncology: SIOPEL 2. Eur J Cancer 40:411-421, 2004